Director, Interim Chief Medical Officer · SPRUCE BIOSCIENCES, INC. · SPRUCE BIOSCIENCES, INC. — Restricted Stock Units
Side
M
Value
—
Shares
1,250
Price
—
Executed
Dec 11, 2025
Disclosed
Jan 21, 2026
Disclosure timeline41 days from execution to publication · legal deadline 2 business days
Dec 11 executedJan 21, 2026 disclosed
SPRB · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 50.0% of prior position
Filing timing+10 / 15
Disclosed 29 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Ways Douglas Kirk filed this Form 4 reporting a option exercise of SPRB on Dec 11, 2025. It became public on Jan 21, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Interim Chief Medical Officer
Ways Douglas Kirkcik:0001869391
Issuer
SPRUCE BIOSCIENCES, INC.cik:0001683553
Revision history · 0
No field has changed since this record was first ingested.
